← Eichor
Study identifier: NCT06087692 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Video-Based Interactive Game Therapy in Interstitial Lung Patients

Condition: Interstitial Lung Disease  ·  Sponsor: Istanbul University

PhaseNA
Planned participants30
Who can joinAll sexes, 40 Years to 65 Years
Healthy volunteersYes

About this study

Interstitial lung disease (ILD) is a heterogeneous group of diseases consisting of variable amounts of inflammation and fibrosis and a wide variety of acute and chronic pulmonary disorders affecting both the interstitium and lung parenchyma. The use of gamification elements in order to encourage changes in health behaviors such as physical activity appears as an entertaining option by increasing extrinsic motivation in sedentary individuals or in diseases where physical activity is targeted. The aim of this study is to investigate the effectiveness of Nintendo Wii applied in addition to aerobic exercise in patients with ILD on exercise capacity and peripheral muscle strength, symptoms, activity and participation with objective methods, based on evidence.

This description comes directly from the study's public registry record.

Talk to the study team

Melike Sarıtaş Arslan, PhdC  ·  5542320882  ·  mlksrts@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

İstanbul Faculty of MedicineIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06087692